Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Relational Investors Report 7.3% Position in Hologic, Inc. (HOLX)

Relational Investors fund managed by Ralph Whitworth has revealed holding 19.95 million shares of Hologic, Inc. (NASDAQ:HOLX). The stake is activist by nature and amasses 7.3% of the company’s common stock. The stake has been boosted from around 12.0 million shares, reported by Relational as being held at the end of September, according to an amendment to its 13F filing.

Hologic, Inc. (NASDAQ:HOLX)

Hologic, Inc. (NASDAQ:HOLX), has been quietly endorsed by analysts such as Needham, on the appointment of new CEO-Steve MacMillan. As the ex-chief of Stryker, MacMillan is expected to deliver on expectations. Also stepping on board with him will be two Managing Directors appointed by Carl Icahn.

Hologix, which is US-based diagnostic and surgical equipment makers for specialty imaging of women’s healthcare such as – breast health, skeletal health as well as a spectrum of gynecological issues as well.

Relational Investors increase in stake in Hologic, Inc. (NASDAQ:HOLX), is despite the downgrade, analysts at Cowen proposed. According to them, the company will not see much of revenues gaining acceleration.

Currently, other funds also hold stakes in Hologic, Inc. (NASDAQ:HOLX), aside from Relational Investors fund, which, at the end of September, held the largest position, in terms of amount of shares out of the funds we track. John A. Levin’s Levin Capital Strategies owns over 4.6 million shares, worth $94.42 million. Meanwhile Barry Rosenstein’s Jana Partners significantly boosted its position during the third quarter, currently holding 3.6 million shares, worth almost $73.53 million.

Earlier in November, Carl Icahn invested in Hologic, Inc. (NASDAQ:HOLX). Analysts could only assume that this would fast-track the value-addition the company was proposing, when Icahn has its representatives on Hologic’s, board. Analysts such as Matson viewed the move as pre-empting a complete sale of the company as well.

Disclosure: none

Recommended Reading:

Abrams Capital Management Adds Global Eagle Entratainment (ENT) to Its Equity Portfolio; Reveals 6.0% Stake

QVT Financial is Bullish on China Zenix Auto International Ltd (ZX); Boosts the Stake to 6.7%

Deerfield Management Initiates Passive Stake in Horizon Pharma Inc (HZNP)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!